| Disease | GINKGO BILOBA AND BACOPA MONNIERA HAD NO COGNITIVE ENHANCING EFFECTS IN HEALTHY SUBJECTS.
CONSOLIDATION, EXECUTIVE PROCESSES, PLANNING AND PROBLEM SOLVING, INFORMATION PROCESSING SPEED, MOTOR RESPONSIVENESS AND DECISION MAKING. THESE FINDINGS SUGGEST THAT AT LEAST WITHIN THE CURRENT TREATMENT DURATION AND DOSES, AN EXTRACT CONTAINING
THE RESULTS SHOWED THAT THE COMBINED EXTRACT RELATIVE TO PLACEBO DID NOT DEMONSTRATE ANY SIGNIFICANT EFFECTS ON TESTS INVESTIGATING A RANGE OF COGNITIVE PROCESSES INCLUDING ATTENTION, SHORT TERM AND WORKING MEMORY, VERBAL LEARNING, MEMORY
INDEPENDENT GROUP DESIGN IN WHICH 85 HEALTHY SUBJECTS WERE ALLOCATED TO ONE OF TWO TREATMENT CONDITIONS (PLACEBO OR COMBINED GINKGO BILOBA AND BACOPA MONNIERA EXTRACT). TESTING WAS CONDUCTED AT BASELINE AND 2 AND 4 WEEKS POST TREATMENT.
IN THE CURRENT STUDY SUB-CHRONIC (2 WKS) AND CHRONIC (4 WKS) EFFECTS OF AN EXTRACT CONTAINING GINKGO BILOBA (120 MG) AND BACOPA MONNIERA (300 MG) ON COGNITIVE FUNCTION WERE EXAMINED. THE STUDY WAS A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, |